What are the major opportunities in the Night Blindness Treatment market? What are the strategies for the Night Blindness Treatment market?

For detailed insights on the major opportunities and strategies in the Night Blindness Treatment market, Read More

How does the Night Blindness Treatment market relate to the overall economy and other similar markets?

For detailed insights on Night Blindness Treatment's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Night Blindness Treatment market growth? SWOT analysis of the Night Blindness Treatment market.

For detailed insights on the key dynamics influencing the Night Blindness Treatment market growth and SWOT analysis of the Night Blindness Treatment industry, Read More

Global Night Blindness Treatment Market Report 2025

Report Price : $4490.00

Pages : 175

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF

Purchase This Report

Night Blindness Treatment Global Market Report 2025

Name: Night Blindness Treatment Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Treatment (Medication, Surgery, Other Treatments), By Diagnosis (Blood Tests, Color Vision Testing, Pupil Light Reflex, Refraction, Retinal Exam, Electroretinogram (ERG), Other Diagnoses), By Symptom (Eye Pain, Vomiting, Cloudy Vision, Halos, Light Sensitivity, Distance Vision Problem, Headache, Other Symptoms), By End User (Clinic, Hospital, Other End Users) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Night Blindness Treatment Market Overview

• Night Blindness Treatment market size has reached to $3.95 billion in 2024

• Expected to grow to $5.34 billion in 2029 at a compound annual growth rate (CAGR) of 6.2%

• Growth Driver: Impact Of Increasing Cataract Prevalence On The Night Blindness Treatment Market

• Market Trend: Innovative Genetic Therapies Revolutionizing Night Blindness Treatment Market

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Night Blindness Treatment Market?

Night blindness treatment refers to interventions aiming to alleviate conditions such as vitamin A deficiency and other issues impairing vision in low light settings. It aims to enhance visual acuity in dim conditions and improve overall visual function by addressing underlying causes. The purpose of night blindness treatment is to improve the patient's ability to see in low-light conditions and at night. This treatment aims to address the underlying causes of night blindness and alleviate the symptoms.

The main treatments in the night blindness treatment market are medication, surgery, and other treatments. Night blindness medication refers to treatments aimed at improving vision in low-light conditions, often targeting underlying conditions such as vitamin A deficiency, retinitis pigmentosa, or other retinal disorders. Night blindness can be diagnosed with blood tests, color vision testing, pupil light reflex, refraction, retinal exam, electroretinogram (ERG), and others. The symptoms include eye pain, Vomiting, cloudy vision, halos, light sensitivity, distance vision problem, headache, and others. The end users are clinic, hospital, and others.

Night Blindness Treatment Market Size and growth rate 2025 to 2029: Graph

What Is The Night Blindness Treatment Market Size 2025 And Growth Rate?

What Is The Night Blindness Treatment Market Growth Forecast?

The night blindness treatment market size is expected to see strong growth in the next few years. It will grow to $5.34 billion in 2029 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to increasing adoption of advanced diagnostic technologies, increasing awareness campaigns about eye health, rising demand for personalized medicine, growth in the number of eye care clinics and facilities, growth in healthcare infrastructure development. Major trends in the forecast period include adoption of advanced diagnostic technologies, implementation of personalized treatment, development of gene therapy and stem cell treatments, integration of wearable technology for real time monitoring, development of multi-disciplinary clinics.

The forecast of 6.2% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. adoption of gene therapy for retinitis pigmentosa by inflating prices of retinal implants and vitamin A palmitate formulations developed in Germany and Japan, resulting in worsened vision outcomes and higher ophthalmology costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Night Blindness Treatment Market Segmented?

1) By Treatment: Medication, Surgery, Other Treatments

2) By Diagnosis: Blood Tests, Color Vision Testing, Pupil Light Reflex, Refraction, Retinal Exam, Electroretinogram (ERG), Other Diagnoses

3) By Symptom: Eye Pain, Vomiting, Cloudy Vision, Halos, Light Sensitivity, Distance Vision Problem, Headache, Other Symptoms

4) By End User: Clinic, Hospital, Other End Users

Subsegments:

1) By Medication: Vitamin A Supplements, Retinoid Therapy, Beta-Carotene Supplements, Anti-Glaucoma Medications, Other Pharmaceutical Treatments

2) By Surgery: Cataract Surgery, Retinal Surgery, Corneal Transplantation, LASIK Surgery

3) By Other Treatments: light therapy, Gene Therapy, Low Vision Aids And Assistive Devices, Nutritional Therapy

What Is Driving The Night Blindness Treatment Market? Impact Of Increasing Cataract Prevalence On The Night Blindness Treatment Market

The increasing prevalence of cataracts is expected to propel the growth of the night blindness treatment market going forward. Cataracts refer to a condition where the eye's lens becomes cloudy, leading to impaired vision. The increased exposure to ultraviolet (UV) light from the sun, smoking, and poor diet contribute to the development of cataracts. Cataracts reduce the eye's ability to distinguish between different shades of light and dark, which is crucial for night vision. This decreased contrast sensitivity makes navigating and recognizing objects in low-light environments harder. For instance, in July 2023, according to the 2021-23 National UK Eye Care Statistics Survey conducted by the Well-being of Future Generations Act (WFG), a UK-based government agency, there were an estimated 16,500 (16,510) cataract admissions in 2022-23, an increase of 23.7% from the previous year. Therefore, the increasing prevalence of cataracts is driving the night blindness treatment industry.

Who Are The Major Players In The Global Night Blindness Treatment Market?

Major companies operating in the night blindness treatment market are Johnson & Johnson Private Limited, F. Hoffmann-La Roche Ltd., Bayer AG, Abbott Laboratories, Novartis AG, Boehringer Ingelheim, Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Biogen Inc., Bausch Health Companies Inc., Eisai Co. Ltd, Cipla Inc., Nature's Way, Spark Therapeutics Inc., Garden of Life, Apellis Pharmaceuticals Inc, Solgar, Acucela Inc., Swanson Health Products, NOW Foods

What Are The Key Trends Of The Global Night Blindness Treatment Market? Innovative Genetic Therapies Revolutionizing Night Blindness Treatment Market

Major companies operating in the night blindness treatment market are developing innovative genetic therapies to address the underlying genetic mutations responsible for enhancing treatment efficacy for improved patient outcomes. Genetic therapies help in treating night blindness by targeting and repairing specific genetic mutations that affect retinal function, potentially restoring vision in individuals with inherited retinal disorders such as retinitis pigmentosa. For instance, in August 2023, HuidaGene Therapeutics., a US-based clinical-stage biotechnology company, introduced HG004, a gene therapy designed to treat inherited retinal diseases such as Leber's congenital amaurosis. This therapy has shown superiority over existing treatments in preclinical studies, aiming to restore retinal function and alleviate night blindness and other conditions associated with RPE65-induced impairments.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Night Blindness Treatment Market? Eluminex Biosciences Acquires Zuretinol Rights to Enhance Retinal Disease Pipeline

In January 2022, Eluminex Biosciences, a China-based biotechnology company, acquired global development and commercialization rights for Zuretinol (zuretinol acetate) from Retinagenix Holdings LLC for an undisclosed amount. Through this acquisition, Eluminex Biosciences aims to expand its retinal disease pipeline and develop innovative, non-surgical therapies for vision-threatening diseases such as Leber's congenital amaurosis (LCA) and retinal pigments (RP), offering potential treatments for the entire retina and both eyes simultaneously. Retinagenix Holdings is a US-based company developing treatments for night blindness.

What Is The Regional Outlook For The Global Night Blindness Treatment Market?

North America was the largest region in the night blindness treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Night Blindness Treatment Market?

The night blindness treatment market consists of revenues earned by entities by providing services such as diagnostic services, medical management and consultation, surgical interventions, and genetic counseling and testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The night blindness treatment market also includes sales of night vision goggles, retinal implants and prosthetics, electroretinography (ERG) systems, vitamin A supplements, and intraocular injections. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Night Blindness Treatment Industry?

The night blindness treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the night blindness treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Night Blindness Treatment Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$4.2 billion
Revenue Forecast In 2034	$5.34 billion
Growth Rate	CAGR of 6.2% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Treatment: Medication, Surgery, Other Treatments 2) By Diagnosis: Blood Tests, Color Vision Testing, Pupil Light Reflex, Refraction, Retinal Exam, Electroretinogram (ERG), Other Diagnoses 3) By Symptom: Eye Pain, Vomiting, Cloudy Vision, Halos, Light Sensitivity, Distance Vision Problem, Headache, Other Symptoms 4) By End User: Clinic, Hospital, Other End Users Subsegments: 1) By Medication: Vitamin A Supplements, Retinoid Therapy, Beta-Carotene Supplements, Anti-Glaucoma Medications, Other Pharmaceutical Treatments 2) By Surgery: Cataract Surgery, Retinal Surgery, Corneal Transplantation, LASIK Surgery 3) By Other Treatments: Light Therapy, Gene Therapy, Low Vision Aids And Assistive Devices, Nutritional Therapy
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Johnson & Johnson Private Limited, F. Hoffmann-La Roche Ltd., Bayer AG, Abbott Laboratories, Novartis AG, Boehringer Ingelheim, Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Biogen Inc., Bausch Health Companies Inc., Eisai Co. Ltd, Cipla Inc., Nature's Way, Spark Therapeutics Inc., Garden of Life, Apellis Pharmaceuticals Inc, Solgar, Acucela Inc., Swanson Health Products, NOW Foods
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Night Blindness Treatment Market Characteristics

3. Night Blindness Treatment Market Trends And Strategies

4. Night Blindness Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Night Blindness Treatment Growth Analysis And Strategic Analysis Framework

5.1. Global Night Blindness Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Night Blindness Treatment Market Growth Rate Analysis

5.4. Global Night Blindness Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Night Blindness Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Night Blindness Treatment Total Addressable Market (TAM)

6. Night Blindness Treatment Market Segmentation

6.1. Global Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Medication

Surgery

Other Treatments

6.2. Global Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Blood Tests

Color Vision Testing

Pupil Light Reflex

Refraction

Retinal Exam

Electroretinogram (ERG)

Other Diagnoses

6.3. Global Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Eye Pain

Vomiting

Cloudy Vision

Halos

Light Sensitivity

Distance Vision Problem

Headache

Other Symptoms

6.4. Global Night Blindness Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Clinic

Hospital

Other End Users

6.5. Global Night Blindness Treatment Market, Sub-Segmentation Of Medication, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Vitamin A Supplements

Retinoid Therapy

Beta-Carotene Supplements

Anti-Glaucoma Medications

6.6. Global Night Blindness Treatment Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Cataract Surgery

Retinal Surgery

Corneal Transplantation

LASIK Surgery

6.7. Global Night Blindness Treatment Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Light Therapy

Gene Therapy

Low Vision Aids And Assistive Devices

Nutritional Therapy

7. Night Blindness Treatment Market Regional And Country Analysis

7.1. Global Night Blindness Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Night Blindness Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Night Blindness Treatment Market

8.1. Asia-Pacific Night Blindness Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Night Blindness Treatment Market

9.1. China Night Blindness Treatment Market Overview

9.2. China Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Night Blindness Treatment Market

10.1. India Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Night Blindness Treatment Market

11.1. Japan Night Blindness Treatment Market Overview

11.2. Japan Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Night Blindness Treatment Market

12.1. Australia Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Night Blindness Treatment Market

13.1. Indonesia Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Night Blindness Treatment Market

14.1. South Korea Night Blindness Treatment Market Overview

14.2. South Korea Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Night Blindness Treatment Market

15.1. Western Europe Night Blindness Treatment Market Overview

15.2. Western Europe Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Night Blindness Treatment Market

16.1. UK Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Night Blindness Treatment Market

17.1. Germany Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Night Blindness Treatment Market

18.1. France Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Night Blindness Treatment Market

19.1. Italy Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Night Blindness Treatment Market

20.1. Spain Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Night Blindness Treatment Market

21.1. Eastern Europe Night Blindness Treatment Market Overview

21.2. Eastern Europe Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Night Blindness Treatment Market

22.1. Russia Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Night Blindness Treatment Market

23.1. North America Night Blindness Treatment Market Overview

23.2. North America Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Night Blindness Treatment Market

24.1. USA Night Blindness Treatment Market Overview

24.2. USA Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Night Blindness Treatment Market

25.1. Canada Night Blindness Treatment Market Overview

25.2. Canada Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Night Blindness Treatment Market

26.1. South America Night Blindness Treatment Market Overview

26.2. South America Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Night Blindness Treatment Market

27.1. Brazil Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Night Blindness Treatment Market

28.1. Middle East Night Blindness Treatment Market Overview

28.2. Middle East Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Night Blindness Treatment Market

29.1. Africa Night Blindness Treatment Market Overview

29.2. Africa Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Night Blindness Treatment Market Competitive Landscape And Company Profiles

30.1. Night Blindness Treatment Market Competitive Landscape

30.2. Night Blindness Treatment Market Company Profiles

30.2.1. Johnson & Johnson Private Limited Overview, Products and Services, Strategy and Financial Analysis

30.2.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Night Blindness Treatment Market Other Major And Innovative Companies

31.1. Boehringer Ingelheim

31.2. Regeneron Pharmaceuticals Inc.

31.3. Astellas Pharma Inc.

31.4. Biogen Inc.

31.5. Bausch Health Companies Inc.

31.6. Eisai Co. Ltd

31.7. Cipla Inc.

31.8. Nature's Way

31.9. Spark Therapeutics Inc.

31.10. Garden of Life

31.11. Apellis Pharmaceuticals Inc

31.12. Solgar

31.13. Acucela Inc.

31.14. Swanson Health Products

31.15. NOW Foods

32. Global Night Blindness Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Night Blindness Treatment Market

34. Recent Developments In The Night Blindness Treatment Market

35. Night Blindness Treatment Market High Potential Countries, Segments and Strategies

35.1 Night Blindness Treatment Market In 2029 - Countries Offering Most New Opportunities

35.2 Night Blindness Treatment Market In 2029 - Segments Offering Most New Opportunities

35.3 Night Blindness Treatment Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Night Blindness Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Night Blindness Treatment Market, Sub-Segmentation Of Medication, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Night Blindness Treatment Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Night Blindness Treatment Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Night Blindness Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Night Blindness Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Johnson & Johnson Private Limited Financial Performance

Table 79: F. Hoffmann-La Roche Ltd. Financial Performance

Table 80: Bayer AG Financial Performance

Table 81: Abbott Laboratories Financial Performance

Table 82: Novartis AG Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Night Blindness Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Night Blindness Treatment Market, Sub-Segmentation Of Medication, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Night Blindness Treatment Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Night Blindness Treatment Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Night Blindness Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Night Blindness Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Johnson & Johnson Private Limited Financial Performance

Figure 79: F. Hoffmann-La Roche Ltd. Financial Performance

Figure 80: Bayer AG Financial Performance

Figure 81: Abbott Laboratories Financial Performance

Figure 82: Novartis AG Financial Performance

Top Trends Driving Innovation and Change in the Interstitial Lung Disease Market: Innovative Drug Development Initiatives To Improve Interstitial Lung Disease Treatment

Global Intestinal Pseudo-Obstruction Treatment Market Projected to Reach $30.8 Billion by 2029 at a CAGR of 5.6%

Key Developments and Trends Steering the Intestine Cancer Therapeutics Market Forward: Increasing Focus On Product Approvals To Drive The Revenues

Major Trends and Emerging Patterns in the Intravenous Solutions Market: Innovative Syringes Transforming The Intravenous Solutions Market

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Night Blindness Treatment Global Market Report 2025 – By Treatment (Medication, Surgery, Other Treatments), By Diagnosis (Blood Tests, Color Vision Testing, Pupil Light Reflex, Refraction, Retinal Exam, Electroretinogram...

View Report

Retinal Disorder Treatment Global Market Report 2025 – By Type (Macular Degeneration, Diabetic Retinopathy, Other Types), By Dosage Form (Gels, Eye Solutions, Capsules And Tablets, Eye Drops, Ointments), By Distribution ...

View Report

Night Vision Devices Global Market Report 2025 – By Device (Goggles, Monocular And Binoculars, Camera, Glasses, Scopes, Other Devices), By Technology (Thermal Imaging, Image Intensifier, Infrared Illumination, Other Tech...

View Report

Optic Nerve Disorders Treatment Global Market Report 2025 – By Treatment Type (Steroidal Therapy, Immunomodulators therapy, Other Treatment Types), By Indication (Glaucoma, Optic Neuritis, Optic Neuropathy, Congenital Op...

View Report

Light Therapy Global Market Report 2025 – By Product (Light Box, Floor And Desk Lamps, Handheld Devices For Skin Treatment, Light Visor, Dawn Simulator, Light Therapy Lamps, Other Products), By Light Type (White Light, B...

View Report

Ocular Hypertension Treatment Global Market Report 2025 – By Type (Intraocular Hypertension, Glaucoma), By Route of Administration (Oral, Parenteral, Other Routes), By Distribution Channel (Hospital Pharmacy, Retail Phar...

View Report

Ocular Inflammation Treatment Global Market Report 2025 – By Treatment Type (Immunosuppressant, Antivirals, Corticosteroids, Antibiotics, Analgesics, Monoclonal Antibodies, Antifungal, Cycloplegic), By Mode of Operation ...

View Report

Automotive Night Vision System Global Market Report 2025 – By Component Type (Night Vision Camera, Sensor, Display Unit, Controlling Unit, Other Components), By Technology (Far Infrared (FIR), Near-Infrared (NIR)), By Di...

View Report

Frequently Asked Questions

What is the definition of the Night Blindness Treatment market?

How will the Night Blindness Treatment market drivers and restraints affect the market dynamics? What forces will shape the Night Blindness Treatment industry going forward?

The market major growth driver - Impact Of Increasing Cataract Prevalence On The Night Blindness Treatment Market. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the Night Blindness Treatment market?

The night blindness treatment market size has grown strongly in recent years. It will grow from $3.95 billion in 2024 to $4.2 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to rising prevalence of vitamin A deficiency, growth in the geriatric population prone to night vision problems, expansion of healthcare infrastructure, increasing focus on nutritional interventions for vision health, rising incidence of retinitis pigmentosa. The night blindness treatment market size is expected to see strong growth in the next few years. It will grow to " $5.34 billion in 2029 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to increasing adoption of advanced diagnostic technologies, increasing awareness campaigns about eye health, rising demand for personalized medicine, growth in the number of eye care clinics and facilities, growth in healthcare infrastructure development. Major trends in the forecast period include adoption of advanced diagnostic technologies, implementation of personalized treatment, development of gene therapy and stem cell treatments, integration of wearable technology for real time monitoring, development of multi-disciplinary clinics. For further insights on this market, request a sample here

How is the Night Blindness Treatment market segmented?

The night blindness treatmentmarket covered in this report is segmented –
1) By Treatment: Medication; Surgery; Other Treatments
2) By Diagnosis: Blood Tests; Color Vision Testing; Pupil Light Reflex; Refraction; Retinal Exam; Electroretinogram (ERG); Other Diagnoses
3) By Symptom: Eye Pain; Vomiting; Cloudy Vision; Halos; Light Sensitivity; Distance Vision Problem; Headache; Other Symptoms
4) By End User: Clinic; Hospital; Other End Users Subsegments:
1) By Medication: Vitamin A Supplements; Retinoid Therapy; Beta-Carotene Supplements; Anti-Glaucoma Medications; Other Pharmaceutical Treatments
2) By Surgery: Cataract Surgery; Retinal Surgery; Corneal Transplantation; LASIK Surgery
3) By Other Treatments: Light Therapy; Gene Therapy; Low Vision Aids And Assistive Devices; Nutritional Therapy For further insights on this market, request a sample here

Which region has the largest share of the Night Blindness Treatment market? What are the other regions covered in the report?

North America was the largest region in the night blindness treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the night blindness treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Who are the major players in the Night Blindness Treatment market?

What are the key trends in the Night Blindness Treatment market?

Major trends in this market include Innovative Genetic Therapies Revolutionizing Night Blindness Treatment Market. For further insights on this market, request a sample here.

Book your 30 minutes free consultation with our research experts

Night Blindness Treatment Global Market Report 2025

Night Blindness Treatment Market Overview

What Is Covered Under Night Blindness Treatment Market?

What Is The Night Blindness Treatment Market Size 2025 And Growth Rate?

What Is The Night Blindness Treatment Market Growth Forecast?

What’s The Trade War Impact On Healthcare Services Industry?

How Is The Night Blindness Treatment Market Segmented?

What Is Driving The Night Blindness Treatment Market? Impact Of Increasing Cataract Prevalence On The Night Blindness Treatment Market

Who Are The Major Players In The Global Night Blindness Treatment Market?

What Are The Key Trends Of The Global Night Blindness Treatment Market? Innovative Genetic Therapies Revolutionizing Night Blindness Treatment Market

What Are Latest Mergers And Acquisitions In The Night Blindness Treatment Market? Eluminex Biosciences Acquires Zuretinol Rights to Enhance Retinal Disease Pipeline

What Is The Regional Outlook For The Global Night Blindness Treatment Market?

What Defines the Night Blindness Treatment Market?

How is Market Value Defined and Measured?

What is the Market Assessment and Strategic Outlook for the Night Blindness Treatment Industry?

Night Blindness Treatment Market Report Forecast Analysis

Table Of Contents

List Of Tables

List Of Figures

Frequently Asked Questions